Similar articles

• Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

  Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M. Pardo Y, et al. J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921463
• Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

  Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer. Ferrer M, et al. Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9. Radiother Oncol. 2013. PMID: 23849168
• Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

  Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG. Wei JT, et al. J Clin Oncol. 2002 Jan 15;20(2):557-66. doi: 10.1200/JCO.2002.20.2.557. J Clin Oncol. 2002. PMID: 11786586
• Health-related quality of life and morbidity in patients receiving brachytherapy for clinically localized prostate cancer.

  Krumholtz JS, Michalski JM, Sundaram CP. Krumholtz JS, et al. J Endourol. 2000 May;14(4):371-4. doi: 10.1089/end.2000.14.371. J Endourol. 2000. PMID: 10910154 Review.
• Health-related quality of life after prostate brachytherapy.

  Miller NL, Theodorescu D. Miller NL, et al. BJU Int. 2004 Sep;94(4):487-91. doi: 10.1111/j.1464-410X.2003.04989.x. BJU Int. 2004. PMID: 15329098 Review. No abstract available.